Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere's disease? A critical analysis of published interventional studies.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27623821)

Published in Eur Arch Otorhinolaryngol on September 13, 2016

Authors

Petros V Vlastarakos1,2, Emily Iacovou3, Thomas P Nikolopoulos4

Author Affiliations

1: ENT Department, MITERA Infirmary, 6 Erythrou Stavrou Street, 15123, Marousi-Athens, Greece. pevlast@hotmail.com.
2: , 58 Laskaridou Street, 17676, Kallithea-Athens, Greece. pevlast@hotmail.com.
3: ENT Department, General Hospital of Larnaca, Larnaca, Cyprus.
4: ENT Department, Attikon University Hospital, Athens, Greece.

Articles cited by this

Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg (1995) 5.91

Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol (2004) 2.54

Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope (1999) 2.08

Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol (2009) 1.46

Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg (2000) 1.35

Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today (2005) 1.22

Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database Syst Rev (2011) 1.16

Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope (2001) 1.13

Ablation therapy for the relief of Ménière's disease. Laryngoscope (1956) 1.12

Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope (2004) 1.10

Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol (2000) 1.10

Inner ear perfusion and the role of round window patency. Am J Otol (1997) 1.02

Factors influencing quality of life in patients with Ménière's disease, identified by a multidimensional approach. Otol Neurotol (2002) 0.97

Impact of Ménière's disease on quality of life. Otol Neurotol (2001) 0.96

Outcomes of intratympanic gentamicin injection to treat Ménière's disease. Otol Neurotol (2012) 0.96

Continuous intratympanic infusion of gentamicin via a microcatheter in Menière's disease. Otolaryngol Head Neck Surg (2001) 0.91

Systematic review of intratympanic gentamicin in Meniere's disease. J Otolaryngol (2003) 0.89

Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg (1999) 0.89

Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol (2000) 0.86

Meniere's disease: Still a mystery disease with difficult differential diagnosis. Ann Indian Acad Neurol (2011) 0.85

Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol (2009) 0.83

What is the effect of dizziness on the quality of life for patients with Meniere's disease? Rev Laryngol Otol Rhinol (Bord) (2005) 0.83

Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function. Otolaryngol Head Neck Surg (2005) 0.81

Long-term results of gentamicin inner ear perfusion in Ménière's disease. J Laryngol Otol (2004) 0.81

Microdose gentamicin administration via the round window microcatheter: results in patients with Meniere's disease. Ann N Y Acad Sci (2001) 0.79

Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière's disease. Ear Nose Throat J (2006) 0.79

[Treatment of Ménière's disease. Middle ear infusion with lidocaine and steroid solution]. Auris Nasus Larynx (1986) 0.78

Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome. J Laryngol Otol (2008) 0.78

Middle ear gentamicin-soaked pledgets in the treatment of Ménière's disease. Otol Neurotol (2014) 0.78

Round-Window Microcatheter-Administered Microdose Gentamicin: Results from Treatment of Tinnitus Associated with Menière's Disease. Int Tinnitus J (1998) 0.78

Round window gentamicin mu-catheter--a new therapeutic tool in Ménière's disease. Acta Otolaryngol Suppl (2000) 0.78

Management of intractable Ménière's disease after intratympanic injection of gentamicin. Laryngoscope (2014) 0.77

Continuous gentamicin therapy using an IntraEAR microcatheter for Meniere's disease: a retrospective study. Otolaryngol Head Neck Surg (2002) 0.77

Round window surgery. Otol Neurotol (2010) 0.75